5Bar-Or D, Bar-Or R, Rael LT, et al. Heterogeneity and oxidation status of commercial albumin preparations in clinical use [J].Crit Care Med,2005,33(7) :1638-1641. 被引量：1
6Tanzi M,Gardner M,Megcllas M,et al. Evaluation of the appropriate use of albumin in adult and pediatric patients[J].Am J Health Syst Pharm ,2003,60( 13 ) : 1330-1335. 被引量：1
9Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critical ill patients:systematic review of randomized controlled trials[J].Br Med J, 1998, 317:235. 被引量：1
10Offringa M. Excess mortality after human albumin administration in critrcally ill patients[J] . Br Med J, 1998, 317: 223. 被引量：1
5Vermeulen LC Jr,Ratko TA,Erstad BL,et al. A paradigm for con- sensus. The University Hospital Consortium guidelines for the use of albumin, nonproteincolloid, and crystalloid solutions [ J ]. Arch Intern Med, 1995,155 (4) :373 - 379. 被引量：1
7The University Hospita I Consortium.Adapted from UHC Guidelines for the Use of A1bumin,Nonprotein Colloid,and crystalloid solutions[S].2000-05-01. 被引量：1
